Andras Bors

Budapest, BU, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Genetic factors underlying the susceptibility to SARS-CoV-2 infection and severe COVID-19

Genetic factors underlying the susceptibility to SARS-CoV-2 infection and severe COVID-19

Journal: Orvosi hetilap

Published: February 07, 2025

Diagnostic approaches and clinical relevance of hereditary hematological malignancies

Diagnostic approaches and clinical relevance of hereditary hematological malignancies

Journal: Magyar onkologia

Published: October 07, 2024

Detection of microchimerism with high sensitivity droplet digital PCR technique and its significance in monitoring of hematopoietic stem cell transplanted patients

Detection of microchimerism with high sensitivity droplet digital PCR technique and its significance in monitoring of hematopoietic stem cell transplanted patients

Journal: Orvosi hetilap

Published: December 18, 2023

IGH::NSD2 Fusion Gene Transcript as Measurable Residual Disease Marker in Multiple Myeloma.

IGH::NSD2 Fusion Gene Transcript as Measurable Residual Disease Marker in Multiple Myeloma.

Journal: Cancers

Published: November 30, 2023

Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation.

Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation.

Journal: The journal of pathology. Clinical research

Published: July 26, 2023

Liquid biopsy-based monitoring of residual disease in multiple myeloma by analysis of the rearranged immunoglobulin genes-A feasibility study.

Liquid biopsy-based monitoring of residual disease in multiple myeloma by analysis of the rearranged immunoglobulin genes-A feasibility study.

Journal: PloS one

Published: January 30, 2023

Non-malignant, non-infectious lymphoproliferation: challenges in the diagnosis and treatment of autoimmune lymphoproliferative syndrome

Non-malignant, non-infectious lymphoproliferation: challenges in the diagnosis and treatment of autoimmune lymphoproliferative syndrome

Journal: Orvosi hetilap

Published: July 13, 2021

Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia.

Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia.

Journal: PloS one

Published: February 19, 2021

Optimising the mutation screening strategy in Marfan syndrome and identifying genotypes with more severe aortic involvement.

Optimising the mutation screening strategy in Marfan syndrome and identifying genotypes with more severe aortic involvement.

Journal: Orphanet journal of rare diseases

Published: June 07, 2020

Importance of next generation sequencing in precision oncology approach of acute myeloid leukemia

Importance of next generation sequencing in precision oncology approach of acute myeloid leukemia

Journal: Magyar onkologia

Published: October 16, 2019

Current Trends in Applications of Circulatory Microchimerism Detection in Transplantation.

Current Trends in Applications of Circulatory Microchimerism Detection in Transplantation.

Journal: International journal of molecular sciences

Published: August 04, 2019

Donor KIR2DS1 reduces the risk of transplant related mortality in HLA-C2 positive young recipients with hematological malignancies treated by myeloablative conditioning.

Donor KIR2DS1 reduces the risk of transplant related mortality in HLA-C2 positive young recipients with hematological malignancies treated by myeloablative conditioning.

Journal: PloS one

Published: January 02, 2019

Showing 1-12 of 30

Last Updated: 09/26/2026